Strategic Deployments
Market access is a structural challenge, not a scientific one. I architect the commercial engines that prevent 'Scientific Narcissism' from killing great innovation. Below are select deployments where clinical potential was converted into economic reality.
Case Deployments: Clinical to Economic Translation
National Behavioral Health Expansion
Medicare Market Entry & Partnership Architecture
I led the evaluation and entry strategy for a tech-enabled behavioral health platform across Medicare Part B, MA, D-SNP, and C-SNP segments. This involved developing the comprehensive business case and GTM model, including pressure-testing the durability of unit economics. I directed the outreach to health systems and payers to identify strategic champions, navigating the complex procurement and clinical integration layers of both Academic Medical Centers (AMCs) and PE-backed provider roll-ups.
Defined requirements for partnership models and time-to-pilot, resulting in national launch strategies covering 100M+ lives and $50M in new payer contract value.
Clinical Workflow Optimization
Prior Authorization & Physician Efficiency Systems
Administrative friction in prior authorization was stalling clinical throughput and straining payer-provider relationships. I redesigned end-to-end clinical workflows to automate approvals for high-performing physicians, aligning clinical needs with administrative efficiency. This work established the operational framework for high-trust payer-provider partnerships and streamlined the path to clinical intervention.
Identified opportunities to reduce processing time by 25% per claim.
PE-Backed Health System Roll-up
Reimbursement Optimization & Site-of-Care Architecture
A fragmented health system roll-up faced significant revenue leakage and inconsistent payer contracting, threatening the projected EBITDA of the portfolio. I developed a comprehensive remediation strategy that standardized inpatient and outpatient reimbursement models and optimized site-of-care delivery to align clinical delivery with the highest-value reimbursement.
Located $10M+ in annual revenue leakage and architected the strategic negotiation framework for new enterprise payer contracts, establishing a repeatable commercial model for future portfolio acquisitions.
Enterprise Medicare & Medicaid Strategy
Portfolio Growth & Member Activation
Crafted enterprise strategies for a $78B revenue portfolio across D-SNP, C-SNP, and Group MA segments. Developed C-suite business cases for technology investments and venture/M&A partnerships.
Influenced strategy for a 5.2M-member portfolio and prepared leadership for critical CMS regulatory engagements.
Life Sciences Business Unit Launch
Specialty Biologic Market Access
Led the creation of a new Life Sciences business line focusing on specialty biologics in the home infusion site of care. Analyzed first-of-its-kind datasets to develop go-forward recommendations for the business unit CEO.
Architected the product roadmap and site-of-care strategy used to drive enterprise adoption and identify unique market opportunities.
Cardiovascular Med-Tech GTM
Med-Tech Commercialization Strategy
Directed the pre-marke strategy for a Series A cardiology diagnostic startup. Built a scalable sales pipeline and partnership framework to bridge the gap between clinical clearance and market adoption.
Established the reimbursement pathways and strategic partnerships necessary for immediate post-market viability.
The Verdict: Professionalism & Rigor
Our firm has depended on Tom for his professionalism, rigor, and business acumen. He has shown a strong ability to proactively manage discrete objectives—impressively leading the creation of a new business line for a portfolio company focusing on life sciences. Tom possesses highly marketable skills at the intersection of life sciences, provider, and payer.” — Partner, Growth Equity Firm